Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? [electronic resource]
Producer: 20010802Description: 3250-6 p. digitalISSN:- 0021-972X
- Adult
- Anti-Inflammatory Agents -- pharmacology
- Blood Glucose -- analysis
- C-Reactive Protein -- analysis
- Chemokine CCL2 -- blood
- Cholesterol -- blood
- Chromans -- pharmacology
- Diabetes Mellitus -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Female
- Humans
- I-kappa B Proteins -- blood
- Insulin -- blood
- Intercellular Adhesion Molecule-1 -- blood
- Leukocytes, Mononuclear -- metabolism
- Linoleic Acid -- blood
- Linoleic Acids -- blood
- Linoleic Acids, Conjugated
- Male
- Middle Aged
- NADPH Oxidases
- NF-kappa B -- antagonists & inhibitors
- Neutrophils -- metabolism
- Obesity
- Phenylalanine -- blood
- Phosphoproteins -- blood
- Plasminogen Activator Inhibitor 1 -- blood
- Reactive Oxygen Species -- metabolism
- Thiazoles -- pharmacology
- Thiazolidinediones
- Triglycerides -- blood
- Troglitazone
- Tyrosine -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.